sars-cov-2

Documents about sars-cov-2

• EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)#825379ClinicalTrials.gov
• REAl LIfe" Observational Study on the Effectiveness of Evusheld Prophylaxis Against SARS-CoV-2 Omicron Variants in Vaccine Non-responder Immunocompromised Patients#143643ClinicalTrials.gov
• Colorimetric Detection of SARS-CoV-2 and Drug-Resistant pH1N1 Using CRISPR/dCas9#326602KOASAS: KAIST Open Access Self-Archiving System
• Photodynamic Therapy for COVID-19 Prevention#853000ClinicalTrials.gov
• Convalescent Plasma in the Treatment of COVID 19#854912ClinicalTrials.gov
• To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2#873688ClinicalTrials.gov
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2#807446ClinicalTrials.gov
• Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing#6679OpenAlex
• Single-molecule data on SARS-CoV-2 RTC nsp13-helicase interaction#207974Yoda MOAI Feed
• BISMUTH-BASED BICYCLIC PEPTIDE INHIBITORS TARGETING MAIN PROTEASE OF SARS-COV-2#226461DigitalCommons@Kennesaw State University
• Advancing SARS-CoV-2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure#342289KOASAS: KAIST Open Access Self-Archiving System
• A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above#448311ClinicalTrials.gov
• Systematic review of amino acid profiles among COVID-19 patients caused by SARS-CoV-2#642650Europe PMC
• COVID-19 Vaccination in Oncologic Patients#834335ClinicalTrials.gov
• French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study#848523ClinicalTrials.gov
• Carrageenan Nasal Spray for COVID-19 Prophylaxis#329577ClinicalTrials.gov
• Halodine Nasal Antiseptic in Patients With COVID-19#346948ClinicalTrials.gov
• Tabaquismo y Coronavirus#647075Repositorio Hipermedial UNR
• Cyclosporine For The Treatment Of COVID-19(+)#856565ClinicalTrials.gov
• Table 1_CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.docx#202136Figshare
• Membrane-Anchored and Sequence-Oriented Antiviral Activity of Fusion-Inhibitory Lipopeptides Derived from the SARS-CoV-2 Spike Glycoprotein S2 Subunit#330407IRIS
• Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome#865251ClinicalTrials.gov
• Pathogeny of cerebral venous thrombosis in SARS-Cov-2 infection#333940HAL (France)
• Effectiveness of a Novel Respirator With Chitosan Nanoparticles#839628ClinicalTrials.gov
• Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses#160489PLOS
• Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant#194799OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort#284219HAL (France)
• Bases bioquímicas e funcionais dos mecanismos de resistência do ensitrelvir e nirmatrelvir contra polimorfismos naturais protease principal de SARS-CoV-2#368759RI UFSCar
• Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment#635492IRIS
• Pandemic research in a small island society-a narrative review of research contributions during the SARS-CoV-2 pandemic in the Faroe Islands.#646482PubMed
• Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients#834820ClinicalTrials.gov
• PA-001 Ph.1 Study in Healthy and Elderly Subjects#851538ClinicalTrials.gov
• Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)#226316ClinicalTrials.gov
• COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network#408713HAL (France)
• Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic#287351ClinicalTrials.gov
• Booster Vaccination Against COVID-19#394629ClinicalTrials.gov
• Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)#481788ClinicalTrials.gov
• Analyzing SARS-CoV-2 Sequence Patterns by Semantic Trajectories#652798HAL (France)
• A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older#125927ClinicalTrials.gov
• One-pot, ultrasensitive, and multiplex detection of SARS-CoV-2 genes utilizing self-priming hairpin-mediated isothermal amplification#342273KOASAS: KAIST Open Access Self-Archiving System
• Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)#832105ClinicalTrials.gov
• SARS-CoV-2 faecal negativity and gastrointestinal eubiosis in non-severe COVID-19 in Lagos, Nigeria: Négativité fécale du SRAS-CoV-2 et eubiose gastro-intestinale dans le cas du COVID-19 non sévère à Lagos, Nigeria#317173African Journals Online
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection#811977ClinicalTrials.gov
• IgG antibody levels against the SARS-CoV-2 spike protein in mother-child dyads after COVID-19 vaccination.#276167Repisalud
• Emerging Novel SARS-CoV-2 Subvariants and the Advantages of AI-ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development#642597Europe PMC
• Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?#864127ClinicalTrials.gov
• Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa : an observational study#369035University of Pretoria Repository
• Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1#661962HAL (France)
• Ethical Guidelines for SARS-CoV-2 Digital Tracking and Tracing Systems#95667PhilArchive
• Clinical Trial of SARS-CoV-2 mRNA Vaccine in China#253061ClinicalTrials.gov